PPAR-AKTIVIERENDE VERBINDUNG UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG

A COMPOUND REPRESENTED BY THE FOLLOWING FORMULA (I): (WHEREIN EACH OF R₁ AND R₂, WHICH MAY BE IDENTICAL TO OR DIFFERENT FROM EACH OTHER, REPRESENTS A HYDROGEN ATOM, A METHYL GROUP, OR AN ETHYL GROUP; EACH OF R3a, R3b, R4a AND R4b, WHICH MAY BE IDENTICAL TO OR DIFFERNT FROM EACH OTEHR, REPRESENTS A HYDROGEN ATOM, A HALOGEN ATOM, A NITRO GROUP, A HYDROXYL GROUP, A C₁-₄ ALKYL GROUP, A TRIFLUOROMETHYL GROUP, A C₁-₄ ALKOXY GROUP, A C₁-₄ ALKYLCARBONYLOXY GROUP, A di-C₁-₄ ALKYLAMINO GROUP, A C₁-₄ ALKYSULFONYLOXY GROUP, A C₁-₄ ALKYSULFONYL GROUP, A C₁-₄ ALKYSULFINYL GROUP, OR A C₁-₄ ALKYLTHIO GROUP, OR R3a AND R3b, OR R4a AND R4b MAY BE LINKED TOGETHER TO FORM AN ALKYLENEDIOXY GROUP; X REPRESENTS AN OXYGEN ATOM, A SULFUR ATOM, OR N-R5 (R5 REPRESENTS A HYDROGEN ATOM, A C₁-₄ ALKYL GROUP, A C₁-₄ ALKYLSULFONYL GROUP, OR A C₁-₄ ALKYLOXYCARBONYL GROUP); Y REPRESENTS AN OXYGEN ATOM, S (O)₁ (1 IS A NUMBER OF 0 TO 2), A CARBONYL GROUP, A CARBONYLAMINO GROUP, AN AMINOCARBONYL GROUP, A SULFONYLAMINO GROUP, OR AN AMINOSULFONYL GROUP; Z REPRESENTS CH OR N; n IS A NUMBER OF 1 TO 6; AND m IS A NUMBER OF 2 TO 6) OR A SALT THEREOF; AND THERAPEUTIC DRUGS CONTAINING ANY OF SUCH A COMPOUND OR SALT.